{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T13:51:31Z","timestamp":1789480291558,"version":"build-2803163510"},"reference-count":111,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T00:00:00Z","timestamp":1779062400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Non-small cell lung cancer (NSCLC), the most prevalent form of lung malignancy, remains a leading cause of cancer-related mortality despite advances in surgery, targeted therapy, and immunotherapy. A growing body of evidence implicates the tumor immune microenvironment (TIME) as a critical determinant of disease progression, immune evasion, and therapeutic resistance. This review synthesizes current insights into the roles of innate and adaptive immune populations\u2014including tumor-associated macrophages, neutrophils, dendritic cells, mast cells, myeloid-derived suppressor cells, natural killer cells, T cells, and B cells\u2014in shaping tumor dynamics. Special emphasis is placed on the phenotypic plasticity and functional reprogramming of these immune subsets within the TIME. We further discuss the implications of immune cell heterogeneity for immunotherapy response and resistance. By highlighting the interplay between tumor cells and the immune landscape, this review underscores the potential for TIME-informed strategies to optimize patient stratification and advance combinatorial immunotherapeutic approaches in NSCLC.<\/jats:p>","DOI":"10.3389\/fimmu.2026.1778251","type":"journal-article","created":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T05:41:47Z","timestamp":1779082907000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Tumor immune microenvironment in non-small cell lung cancer progression"],"prefix":"10.3389","volume":"17","author":[{"given":"Jie","family":"Jiang","sequence":"first","affiliation":[{"name":"Department of Respiratory and Critical Care Medicine, Zigong First People\u2019s Hospital","place":["Zigong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingqiang","family":"Zhong","sequence":"additional","affiliation":[{"name":"Department of Respiratory and Critical Care Medicine, Zigong First People\u2019s Hospital","place":["Zigong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Oncology, Jiangjin Hospital, School of Medicine, Chongqing University","place":["Chongqing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiya","family":"Zhang","sequence":"additional","affiliation":[{"name":"Institute of Tuberculosis and Thoracic Tumors, Beijing Chest Hospital","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenqiang","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Respiratory and Critical Care Medicine, Zigong First People\u2019s Hospital","place":["Zigong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiping","family":"Deng","sequence":"additional","affiliation":[{"name":"Department of Respiratory and Critical Care Medicine, Zigong First People\u2019s Hospital","place":["Zigong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,5,18]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2025.2875","article-title":"Frequent missed opportunities for earlier diagnosis of advanced-stage colorectal or lung cancer","volume":"185","author":"Zimolzak","year":"2025","journal-title":"JAMA Intern Med"},{"key":"B3","doi-asserted-by":"publisher","first-page":"6680","DOI":"10.3390\/jcm14186680","article-title":"Immune checkpoint inhibitors beyond progression in various solid tumors: A systematic review and pooled analysis","volume":"14","author":"Petrelli","year":"2025"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1038\/nature25183","article-title":"The biology and management of non-small cell lung cancer","volume":"553","author":"Herbst","year":"2018","journal-title":"Nature"},{"key":"B5","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s13045-023-01430-8","article-title":"Novel strategies for cancer immunotherapy: counter-immunoediting therapy","volume":"16","author":"Liu","year":"2023","journal-title":"J Hematol Oncol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.ccell.2023.02.016","article-title":"The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth","volume":"41","author":"de Visser","year":"2023","journal-title":"Cancer Cell"},{"key":"B7","doi-asserted-by":"publisher","first-page":"2025","DOI":"10.3389\/fimmu.2025.1607225","article-title":"The novel functions of chemokines in lung cancer progression","volume":"16","author":"Gong","year":"2025"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2025.116463","article-title":"Metabolic regulation of immunity in the tumor microenvironment","volume":"44","author":"Li","year":"2025","journal-title":"Cell Rep"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3779\/j.issn.1009-3419.2021.102.49","article-title":"Advances in the study of tumor-associated macrophages in lung cancer","volume":"25","author":"Qiao","year":"2022","journal-title":"Zhongguo Fei Ai Za Zhi"},{"key":"B10","doi-asserted-by":"publisher","first-page":"2025","DOI":"10.3389\/fimmu.2025.1658795","article-title":"Progress in targeting tumor-associated macrophages in cancer immunotherapy","volume":"16","author":"Xia","year":"2025"},{"key":"B11","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1007\/s00432-024-05777-4","article-title":"The role of tumor-associated macrophages in tumor immune evasion","volume":"150","author":"Huang","year":"2024","journal-title":"J Cancer Res Clin Oncol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1101\/517003","article-title":"Low-dose IFN\u03b3 induces tumor cell stemness in tumor microenvironment of non-small cell lung cancer","volume":"79","author":"Song","year":"2019","journal-title":"Cancer Res"},{"key":"B13","doi-asserted-by":"publisher","first-page":"2025","DOI":"10.3389\/fonc.2025.1571583","article-title":"The role and clinical significance of tumor-associated macrophages in the epithelial\u2013mesenchymal transition of lung cancer","volume":"15","author":"Liao","year":"2025"},{"key":"B14","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1038\/s41419-024-06919-9","article-title":"PPAR-\u03b3\/NF-kB\/AQP3 axis in M2 macrophage orchestrates lung adenocarcinoma progression by upregulating IL-6","volume":"15","author":"Lin","year":"2024","journal-title":"Cell Death Dis"},{"key":"B15","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.3389\/fimmu.2023.1295257","article-title":"Tumor-associated macrophages: an effective player of the tumor microenvironment","volume":"14","author":"Basak","year":"2023"},{"key":"B16","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/s41698-024-00522-z","article-title":"Targeting M2-like tumor-associated macrophages is a potential therapeutic approach to overcome antitumor drug resistance","volume":"8","author":"Wang","year":"2024","journal-title":"NPJ Precis Oncol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"2025","DOI":"10.3389\/fimmu.2025.1679537","article-title":"Targeting tumor-associated macrophages in non-small cell lung cancer: mechanisms, prognosis, and therapeutic opportunities","volume":"16","author":"Hao","year":"2025"},{"key":"B18","doi-asserted-by":"publisher","first-page":"2025","DOI":"10.3389\/fimmu.2025.1573039","article-title":"Lactate-mediated metabolic reprogramming of tumor-associated macrophages: implications for tumor progression and therapeutic potential","volume":"16","author":"Jin","year":"2025"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2024.09.029","article-title":"FABP5+ lipid-loaded macrophages process tumour-derived unsaturated fatty acid signal to suppress T-cell antitumour immunity","volume":"82","author":"Yang","year":"2025","journal-title":"J Hepatol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1038\/s41420-024-01807-9","article-title":"Fatty acid metabolism of immune cells: a new target of tumour immunotherapy","volume":"10","author":"Zhang","year":"2024","journal-title":"Cell Death Discov"},{"key":"B21","doi-asserted-by":"publisher","first-page":"2025","DOI":"10.3389\/fimmu.2025.1679271","article-title":"Emerging macrophage-based therapies for cancer: a review of preclinical and clinical advances","volume":"16","author":"Brancewicz","year":"2025"},{"key":"B22","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1038\/s41392-025-02325-5","article-title":"Dual roles and therapeutic targeting of tumor-associated macrophages in tumor microenvironments","volume":"10","author":"Xu","year":"2025","journal-title":"Signal Transduct Target Ther"},{"key":"B23","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/s12943-021-01428-1","article-title":"Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives","volume":"20","author":"Mao","year":"2021","journal-title":"Mol Cancer"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1038\/s41467-025-56546-x","article-title":"Spatially mapping the tumour immune microenvironments of non-small cell lung cancer","volume":"16","author":"Desharnais","year":"2025","journal-title":"Nat Commun"},{"key":"B25","doi-asserted-by":"publisher","first-page":"2024","DOI":"10.3389\/fonc.2024.1338634","article-title":"In-depth analysis of immune cell landscapes reveals differences between lung adenocarcinoma and lung squamous cell carcinoma","volume":"14","author":"Wang","year":"2024"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2021012295","article-title":"Neutrophils in acute inflammation: current concepts and translational implications","volume":"139","author":"Margraf","year":"2022","journal-title":"Blood"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1677901","article-title":"Advances in research on the role of neutrophils in organ transplant rejection","volume":"16","author":"Yu","year":"2025","journal-title":"Front Immunol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1186\/s12967-025-07084-z","article-title":"Neutrophils in non-small cell lung cancer and immunotherapy with PD-1\/PD-L1 inhibitors","volume":"23","author":"Hu","year":"2025","journal-title":"J Transl Med"},{"key":"B29","doi-asserted-by":"publisher","first-page":"2025","DOI":"10.3389\/fonc.2025.1705716","article-title":"Prognostic value of tumour-associated neutrophils in different polarization status releasing neutrophil extracellular traps in the immunotherapy of advanced non-small cell lung cancer","volume":"15","author":"Hong","year":"2026"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2025.1584987","article-title":"Metabolic reprogramming of tumor-associated neutrophils in tumor treatment and therapeutic resistance","volume":"13","author":"Lin","year":"2025","journal-title":"Front Cell Dev Biol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"2025","DOI":"10.3389\/fimmu.2025.1721090","article-title":"Mechanistic roles of neutrophil heterogeneity in tumour pathogenesis","volume":"16","author":"Lin","year":"2025"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.32604\/or.2025.069408","article-title":"CXCR1 and CXCR2 antagonism with G31P attenuates chemotherapy-induced lung inflammation and augments the gefitinib therapeutic response in lung cancer","volume":"33","author":"Khan","year":"2025"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2020-002305","article-title":"Tumor-derived lactate inhibit the efficacy of lenvatinib through regulating PD-L1 expression on neutrophil in hepatocellular carcinoma","volume":"9","author":"Deng","year":"2021","journal-title":"J Immunother Cancer"},{"key":"B34","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1038\/s41392-025-02242-7","article-title":"Therapeutic potential of tumor-associated neutrophils: dual role and phenotypic plasticity","volume":"10","author":"Zhou","year":"2025","journal-title":"Signal Transduct Target Ther"},{"key":"B35","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1186\/s12943-024-02004-z","article-title":"Neutrophils in cancer immunotherapy: friends or foes","volume":"23","author":"Huang","year":"2024","journal-title":"Mol Cancer"},{"key":"B36","doi-asserted-by":"publisher","first-page":"2022","DOI":"10.3389\/fcell.2022.938289","article-title":"Roles of tumor-associated neutrophils in tumor metastasis and its clinical applications","volume":"10","author":"Yan","year":"2022"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1177\/17588359251387551","article-title":"Neutrophil extracellular traps predict poor response and prognosis in non-small cell lung cancer immunotherapy","volume":"17","author":"Lv","year":"2025","journal-title":"Ther Adv Med Oncol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.34172\/bi.30671","article-title":"Overview of dendritic cells subsets and their involvement in immune-related pathological disease","volume":"15","author":"Abbaszadeh","year":"2025","journal-title":"Bioimpacts"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.59717\/j.xinn-med.2025.100128","article-title":"Dendritic cells instruct T cell anti-tumor immunity and immunotherapy response","volume":"3","author":"Xiao","year":"2025","journal-title":"Innovation Med"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-023-00990-6","article-title":"Dendritic cell subsets in cancer immunity and tumor antigen sensing","volume":"20","author":"Del Prete","year":"2023","journal-title":"Cell Mol Immunol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-021-00726-4","article-title":"Dendritic cell migration in inflammation and immunity","volume":"18","author":"Liu","year":"2021","journal-title":"Cell Mol Immunol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1016\/j.molimm.2018.03.025","article-title":"Dysfunction of antigen processing and presentation by dendritic cells in cancer","volume":"113","author":"Bandola-Simon","year":"2019","journal-title":"Mol Immunol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"2829","DOI":"10.1007\/978-3-540-77385-6_9","article-title":"Non-small cell lung cancer cells modulate the development of human CD1c(+) conventional dendritic cell subsets mediated by CD103 and CD205","volume":"10","author":"Lu","year":"2019","journal-title":"Front Immunol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11206154","article-title":"Comprehensive analysis of a novel immune-related gene signature in lung adenocarcinoma","volume":"11","author":"Feng","year":"2022","journal-title":"J Clin Med"},{"key":"B45","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1038\/s41419-025-08180-0","article-title":"The emerging role of dendritic cells in the tumor microenvironment: from antigen presentation to targeted immunotherapy","volume":"16","author":"Xie","year":"2025","journal-title":"Cell Death Dis"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2023.2198467","article-title":"Autologous dendritic cells loaded with antigens from self-renewing autologous tumor cells as patient-specific therapeutic cancer vaccines","volume":"19","author":"Dillman","year":"2023","journal-title":"Hum Vaccines Immunother"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2025.2588861","article-title":"A review of vaccinology and ex vivo antigen-loaded dendritic cells: A different approach to infectious disease vaccines","volume":"21","author":"Dillman","year":"2025","journal-title":"Hum Vaccin Immunother"},{"key":"B48","doi-asserted-by":"publisher","first-page":"2025","DOI":"10.3389\/falgy.2025.1668742","article-title":"The recent advances of mast cells in the pathogenesis of atopic dermatitis","volume":"6","author":"Xiao","year":"2025"},{"key":"B49","doi-asserted-by":"publisher","first-page":"2248","DOI":"10.3390\/cancers14092248","article-title":"Comparative study of the role of interepithelial mucosal mast cells in the context of intestinal adenoma-carcinoma progression","volume":"14","author":"Groll","year":"2022"},{"key":"B50","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s00005-023-00676-x","article-title":"Mast cells and resistance to immunotherapy in cancer","volume":"71","author":"Ribatti","year":"2023","journal-title":"Archivum Immunol Ther Exp"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1038\/s41420-024-02258-y","article-title":"Mast cells: key players in digestive system tumors and their interactions with immune cells","volume":"11","author":"Shu","year":"2025","journal-title":"Cell Death Discov"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2025.116863","article-title":"Activated CD38+ mast cells promote gastric cancer progression by suppressing CD8+ T cell cytotoxic activity through adenosine metabolism","volume":"45","author":"Zhao","year":"2026","journal-title":"Cell Rep"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.990463","article-title":"Immunotherapy of targeting MDSCs in tumor microenvironment","volume":"13","author":"Sui","year":"2022","journal-title":"Front Immunol"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1461455","article-title":"Metabolic pathways fueling the suppressive activity of myeloid-derived suppressor cells","volume":"15","author":"Goldmann","year":"2024"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2025.1677201","article-title":"Molecular mechanisms governing the differentiation and expansion of myeloid-derived suppressor cells","volume":"13","author":"Wang","year":"2025"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.7150\/thno.33275","article-title":"Visualization and quantification of in vivo homing kinetics of myeloid-derived suppressor cells in primary and metastatic cancer","volume":"9","author":"Hoffmann","year":"2019","journal-title":"Theranostics"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.740827","article-title":"Myeloid-derived suppressor cells: A multifaceted accomplice in tumor progression","volume":"9","author":"Cheng","year":"2021"},{"key":"B58","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1038\/s41392-021-00670-9","article-title":"Myeloid-derived suppressor cells as immunosuppressive regulators and therapeutic targets in cancer","volume":"6","author":"Li","year":"2021","journal-title":"Signal Transduct Target Ther"},{"key":"B59","doi-asserted-by":"publisher","first-page":"16869","DOI":"10.1038\/s41598-025-01868-5","article-title":"Interleukin-7 enhances recruitment of MDSCs by regulating MCP-1 via JAK1\/STAT3 signaling pathway in non-small cell lung cancer","volume":"15","author":"Cheng","year":"2025","journal-title":"Sci Rep"},{"key":"B60","doi-asserted-by":"publisher","first-page":"68","DOI":"10.3892\/br.2024.1754","article-title":"Myeloid-derived suppressor cell accumulation induces Treg expansion and modulates lung Malignancy progression","volume":"20","author":"Wan","year":"2024","journal-title":"BioMed Rep"},{"key":"B61","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s13045-025-01690-6","article-title":"Current and future therapies for small cell lung carcinoma","volume":"18","author":"Zhai","year":"2025","journal-title":"J Hematol Oncol"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-023-00846-y","article-title":"Myeloid-derived suppressor cells in cancer and cancer therapy","volume":"21","author":"Lasser","year":"2024","journal-title":"Nat Rev Clin Oncol"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1275028","article-title":"Balancing act: the complex role of NK cells in immune regulation","volume":"14","author":"Jiang","year":"2023"},{"key":"B64","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1038\/s41392-024-02005-w","article-title":"Comprehensive snapshots of natural killer cells functions, signaling, molecular mechanisms and clinical utilization","volume":"9","author":"Chen","year":"2024","journal-title":"Signal Transduct Target Ther"},{"key":"B65","doi-asserted-by":"publisher","first-page":"4388","DOI":"10.1038\/s41467-024-48700-8","article-title":"Single-cell and spatial transcriptomics analysis of non-small cell lung cancer","volume":"15","author":"De Zuani","year":"2024","journal-title":"Nat Commun"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1684889","article-title":"Reprogramming the immune microenvironment in lung cancer","volume":"16","author":"Chen","year":"2025"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1286986","article-title":"Modulation of natural killer cell exhaustion in the lungs: the key components from lung microenvironment and lung tumor microenvironment","volume":"14","author":"Zhang","year":"2023"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.17504\/protocols.io.5qpvo3y9xv4o\/v1","article-title":"Metabolic programs drive function of therapeutic NK cells in hypoxic tumor environments","volume":"10","author":"Kennedy","year":"2024","journal-title":"Sci Adv"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1563303","article-title":"Impact of lactate on immune cell function in the tumor microenvironment: mechanisms and therapeutic perspectives","volume":"16","author":"Gu","year":"2025"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1093\/jleuko\/qiag032","article-title":"Adenosine drives suppression of CD16low NK cell responses against HGSC via NKG2A:hLA-E interactions","volume":"118","author":"Nicolela","year":"2026","journal-title":"J Leukoc Biol"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1303605","article-title":"NK cell exhaustion in the tumor microenvironment","volume":"14","author":"Jia","year":"2023"},{"key":"B72","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/s41392-025-02228-5","article-title":"Overexpressing natural killer group 2 member A drives natural killer cell exhaustion in relapsed acute myeloid leukemia","volume":"10","author":"Xie","year":"2025","journal-title":"Signal Transduct Target Ther"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-024-01145-x","article-title":"Development of NK cell-based cancer immunotherapies through receptor engineering","volume":"21","author":"Page","year":"2024","journal-title":"Cell Mol Immunol"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1093\/immadv\/ltad031","article-title":"Harnessing natural killer cell effector function against cancer","volume":"4","author":"Blunt","year":"2024","journal-title":"Immunother Adv"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1420205","article-title":"The basic biology of NK cells and its application in tumor immunotherapy","volume":"15","author":"Jiang","year":"2024"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.115004","article-title":"Natural killer cell-based immunotherapy for cancer","volume":"214","author":"Ma","year":"2025","journal-title":"J Immunol"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.cir-23-0324","article-title":"Preclinical evaluation of off-the-shelf PD-L1+ human natural killer cells secreting IL15 to treat non-small cell lung cancer","volume":"12","author":"Lu","year":"2024","journal-title":"Cancer Immunol Res"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1601773","article-title":"Tumor-infiltrating lymphocytes in cancer immunotherapy: from chemotactic recruitment to translational modeling","volume":"16","author":"Kraja","year":"2025"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1476365","article-title":"Prognostic implications of tumor-infiltrating lymphocytes in non-small cell lung cancer: a systematic review and meta-analysis","volume":"15","author":"Yan","year":"2024"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1016\/j.trecan.2024.07.009","article-title":"CD4+ T cells in antitumor immunity","volume":"10","author":"Montauti","year":"2024","journal-title":"Trends Cancer"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1517959","article-title":"Immunocytes in the tumor microenvironment: recent updates and interconnections","volume":"16","author":"Yu","year":"2025"},{"key":"B82","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/s41392-024-01765-9","article-title":"Harnessing innate immune pathways for therapeutic advancement in cancer","volume":"9","author":"Hu","year":"2024","journal-title":"Signal Transduct Target Ther"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1379376","article-title":"Tissue adaptation of CD4 T lymphocytes in homeostasis and cancer","volume":"15","author":"Pereira","year":"2024"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.982986","article-title":"FOXP3+ regulatory T cells and the immune escape in solid tumours","volume":"13","author":"Qiu","year":"2022"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1038\/s12276-023-01105-x","article-title":"CD8 T-cell subsets: heterogeneity, functions, and therapeutic potential","volume":"55","author":"Koh","year":"2023","journal-title":"Exp Mol Med"},{"key":"B86","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1186\/s12967-025-06291-y","article-title":"New insights on anti-tumor immunity of CD8+ T cells: cancer stem cells, tumor immune microenvironment and immunotherapy","volume":"23","author":"Lin","year":"2025","journal-title":"J Transl Med"},{"key":"B87","doi-asserted-by":"publisher","first-page":"5588","DOI":"10.1038\/s41467-025-60657-w","article-title":"Different tumour-resident memory T-cell subsets regulate responses to anti-PD-1 and anti-CTLA-4 cancer immunotherapies","volume":"16","author":"Damei","year":"2025","journal-title":"Nat Commun"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1452212","article-title":"PD-1 and CTLA-4 serve as major gatekeepers for effector and cytotoxic T-cell potentiation by limiting a CXCL9\/10-CXCR3-IFN\u03b3 positive feedback loop","volume":"15","author":"Abdala-Saleh","year":"2024"},{"key":"B89","doi-asserted-by":"publisher","first-page":"83","DOI":"10.21037\/cco-24-62","article-title":"The differences in the distribution characteristics and prognostic value of tumor-infiltrating T lymphocyte subsets between lung adenocarcinoma and lung squamous cell carcinoma","volume":"13","author":"Zhang","year":"2024"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-025-02351-7","article-title":"Spatial signatures for predicting immunotherapy outcomes using multi-omics in non-small cell lung cancer","volume":"57","author":"Aung","year":"2025","journal-title":"Nat Genet"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2024-sitc2024.0574","article-title":"574 Exclusion of CD8 T cells from tumor epithelium is associated with worse immune checkpoint blockade (ICB) therapy response and survival in non-small cell lung cancer (NSCLC)","volume":"12","author":"Sher","year":"2024","journal-title":"J Immunother Cancer"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-023-02361-4","article-title":"Resistance to immune checkpoint therapies by tumour-induced T-cell desertification and exclusion: key mechanisms, prognostication and new therapeutic opportunities","volume":"129","author":"Wang","year":"2023","journal-title":"Br J Cancer"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1614228","article-title":"Breaking down physical barriers: strategies to improve lymphocyte infiltration for effective neoantigen-based therapies","volume":"16","author":"Chen","year":"2025","journal-title":"Front Immunol"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-025-02327-3","article-title":"Revitalizing T cells: breakthroughs and challenges in overcoming T cell exhaustion","volume":"11","author":"Wu","year":"2026","journal-title":"Signal Transduct Target Ther"},{"key":"B95","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/s41392-025-02505-3","article-title":"Hypoxia induced VEGF secretion promotes resistance to bispecific T-cell engagers","volume":"10","author":"Xu","year":"2025","journal-title":"Signal Transduct Target Ther"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1104771","article-title":"T-cell exhaustion and stemness in antitumor immunity: Characteristics, mechanisms, and implications","volume":"14","author":"Chi","year":"2023"},{"key":"B97","article-title":"B cell development: transcriptional regulation and immunological mechanisms in homeostasis","volume":"16","author":"G\u00f3mez-Manr\u00edquez","year":"2025"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.109961","article-title":"Temporal dynamics of persistent germinal centers and memory B cell differentiation following respiratory virus infection","volume":"37","author":"Yewdell","year":"2021","journal-title":"Cell Rep"},{"key":"B99","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/j.immuni.2022.02.001","article-title":"Tertiary lymphoid structures generate and propagate anti-tumor antibody-producing plasma cells in renal cell cancer","volume":"55","author":"Meylan","year":"2022","journal-title":"Immunity"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.cd-21-1658","article-title":"The single-cell immunogenomic landscape of B and plasma cells in early-stage lung adenocarcinoma","volume":"12","author":"Hao","year":"2022","journal-title":"Cancer Discov"},{"key":"B101","doi-asserted-by":"publisher","first-page":"699","DOI":"10.21037\/jtd-22-206","article-title":"Machine learning-based screening of the diagnostic genes and their relationship with immune-cell infiltration in patients with lung adenocarcinoma","volume":"14","author":"Wang","year":"2022","journal-title":"JJoTD"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1649812","article-title":"The dual immunomodulatory role of B cells in tumorigenesis: mechanisms, microenvironment crosstalk, and therapeutic implications","volume":"16","author":"Lv","year":"2025"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2024.117436","article-title":"Tumor-infiltrating B cells: their dual mechanistic roles in the tumor microenvironment","volume":"179","author":"Xue","year":"2024","journal-title":"Biomed Pharmacother"},{"key":"B104","doi-asserted-by":"publisher","first-page":"11825","DOI":"10.3390\/ijms252111825","article-title":"The dual role of B cells in the tumor microenvironment: implications for cancer immunology and therapy","volume":"25","author":"Yang","year":"2024"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1595408","article-title":"Comprehensive analysis of regulatory B cell related genes in prognosis and therapeutic response in lung adenocarcinoma","volume":"16","author":"Zhang","year":"2025"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1007\/s13402-025-01052-x","article-title":"Spatial distribution of tertiary lymphoid structures in the molecular and clinical context of non-small cell lung cancer","volume":"48","author":"Elfving","year":"2025","journal-title":"Cell Oncol"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.626776","article-title":"Tertiary lymphoid structure-B cells narrow regulatory T cells impact in lung cancer patients","volume":"12","author":"Germain","year":"2021"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.678127","article-title":"B cell orchestration of anti-tumor immune responses: a matter of cell localization and communication","volume":"9","author":"Kinker","year":"2021"},{"key":"B109","doi-asserted-by":"publisher","first-page":"2104426","DOI":"10.1080\/2162402X.2022.2104426","article-title":"Enriched circulating and tumor-resident TGF-\u03b2(+) regulatory B cells in patients with melanoma promote FOXP3(+) Tregs","volume":"11","author":"Harris","year":"2022","journal-title":"Oncoimmunology"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.4110\/in.2024.24.e8","article-title":"Cytokines in follicular helper T cell biology in physiologic and pathologic conditions","volume":"24","author":"Choi","year":"2024","journal-title":"Immune Netw"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1214095","article-title":"NF-kB\u2019s contribution to B cell fate decisions","volume":"14","author":"Guldenpfennig","year":"2023"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1778251\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T05:41:50Z","timestamp":1779082910000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1778251\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,18]]},"references-count":111,"alternative-id":["10.3389\/fimmu.2026.1778251"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1778251","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,18]]},"article-number":"1778251"}}